Healthcare systems and chronic kidney disease: putting the patient in control

被引:15
|
作者
Ronco, Claudio [1 ,2 ]
Mason, Giacomo [1 ]
Karopadi, Akash Nayak [1 ,3 ,4 ]
Milburn, Alan [5 ]
Hegbrant, Jorgen [6 ]
机构
[1] San Bortolo Hosp, Int Renal Res Inst Vicenza IRRIV, Vicenza, Italy
[2] San Bortolo Hosp, Dept Nephrol Dialysis & Transplantat, Vicenza, Italy
[3] BITS Pilani, Dept Chem Engn, Pilani, Rajasthan, India
[4] BITS Pilani, Dept Econ, Pilani, Rajasthan, India
[5] Diaverum Sweden AB, Lund, Sweden
[6] Diaverum Renal Serv Grp, Corp Med Off, Lund, Sweden
关键词
CKD; dialysis; health policy; HEMODIALYSIS; BURDEN;
D O I
10.1093/ndt/gft457
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
aEuro broken vertical bar rather than restricting choice, as happens with legislation (i.e. a shove), nudges are designed to increase the likelihood that the more responsible choice is madeaEuro broken vertical bar.Today, health policy seems to be on the top of governments' agendas around the world. Healthcare systems are challenged by a number of phenomena happening on a global scale; these trends include demographic change in terms of an ageing population, an increase in chronic disease, patients having higher expectations on healthcare delivery and above all a major pressure on public finances to slow increasing healthcare expenditures. Such developments are forcing policy-makers to reform healthcare systems. First, there is a tendency towards decentralization of responsibilities. Second, governments are moving towards reimbursement schemes rewarding good outcomes and performance. Third, great importance is being attributed to transparency and accountability, and to introduce competition in healthcare. Fourth, attention is being shifted from simple treatment of a disease towards preventive initiatives, in a more holistic approach to health. Finally, healthcare policy-makers are recognizing the importance of empowering patients to give them control over decisions regarding their own health. These dynamics can be observed in chronic kidney disease, the management of which is a huge economic burden to healthcare systems globally, and which represents a good example of a field where important changes can be witnessed in therapy, technology, delivery and financing.
引用
收藏
页码:958 / 963
页数:6
相关论文
共 50 条
  • [31] Pregnancy in Chronic Kidney Disease
    Shehaj, Larisa
    Kazancioglu, Rumeyza
    KIDNEY AND DIALYSIS, 2023, 3 (02): : 152 - 162
  • [32] Microbiome in Chronic Kidney Disease
    Tourountzis, Theodoros
    Lioulios, Georgios
    Fylaktou, Asimina
    Moysidou, Eleni
    Papagianni, Aikaterini
    Stangou, Maria
    LIFE-BASEL, 2022, 12 (10):
  • [33] Does community-wide chronic kidney disease management improve patient outcomes?
    Rayner, Hugh C.
    Baharani, Jyoti
    Dasgupta, Indranil
    Suresh, Vijayan
    Temple, Robert M.
    Thomas, Mark E.
    Smith, Steve A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (03) : 644 - 649
  • [34] Dialysis Disequilibrium Syndrome in a Patient With Acute Kidney Injury on Chronic Kidney Disease
    Sanada, Hajime
    Yamaguchi, Kaori
    Miyake, Taito
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [35] Development of Artificial Intelligence Systems for Chronic Kidney Disease
    Kanda, Eiichiro
    JMA JOURNAL, 2025, 8 (01): : 48 - 56
  • [36] The true cost of phosphate control in chronic kidney disease
    Rodelo-Haad, Cristian
    Rodriguez-Ortiz, Maria E.
    Garcia-Saez, Raquel
    Rivas-Dominguez, Antonio
    Jurado-Montoya, Daniel
    Martin-Malo, Alejandro
    Rodriguez, Mariano
    de Mier, M. Victoria Pendon-Ruiz
    Munoz-Castaneda, Juan Rafael
    CLINICAL KIDNEY JOURNAL, 2025, 18 : i46 - i60
  • [37] Pharmacokinetics of dasatinib in a hemodialysis patient with chronic myeloid leukemia and chronic kidney disease
    Mori, Jinichi
    Oshima, Kumi
    Tanimoto, Tetsuya
    Ishizuka, Hikari
    Kimura, Shinya
    Miura, Masatomo
    Takahashi, Naoto
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (01) : 115 - 117
  • [38] Pharmacokinetics of dasatinib in a hemodialysis patient with chronic myeloid leukemia and chronic kidney disease
    Jinichi Mori
    Kumi Oshima
    Tetsuya Tanimoto
    Hikari Ishizuka
    Shinya Kimura
    Masatomo Miura
    Naoto Takahashi
    International Journal of Hematology, 2020, 112 : 115 - 117
  • [39] Leadless pacemaker placement in a patient with chronic kidney disease: A strategy to preserve central veins
    Maradey, Joan Alberto
    Jao, Geoffrey Te
    Vachharajani, Tushar J.
    HEMODIALYSIS INTERNATIONAL, 2018, 22 (04) : E57 - E59
  • [40] Dietary control of metabolic acidosis in chronic kidney disease
    Laboux, Timothee
    Azar, Raymond
    NEPHROLOGIE & THERAPEUTIQUE, 2019, 15 (07): : 491 - 497